Central venous disease in hemodialysis patients
Kidney Research and Clinical Practice
;
: 309-317, 2019.
Article
in English
| WPRIM
| ID: wpr-759010
ABSTRACT
Central venous disease (CVD) is difficult to treat and often resistant to treatment. In CVD, hemodialysis vascular access should sometimes be abandoned, or in serious cases, the patient's life may be threatened. Therefore, prevention is ideal. However, as the prevalence of chronic kidney disease (CKD) has increased steadily with population aging, CKD patients with a peripherally inserted central catheter (PICC) are encountered frequently. PICCs can cause CVD, and the basilic vein, which is regarded as the important last option for native arteriovenous fistula (AVF) creation in end-stage renal disease (ESRD) patients, is destroyed frequently after its use as the entry site of PICC. The most well-established risk factors for CVD are a history of central venous catheter (CVC) insertion and its duration of use. Therefore, to reduce the incidence of CVD, catheterization in the central vein (CV) should be minimized, along with its duration of use. In this review, we will first explain the basic territories of the CV and introduce its pathophysiology, clinical features, and advanced treatment options. Finally, we will emphasize prevention of CVD.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Veins
/
Aging
/
Catheterization
/
Incidence
/
Prevalence
/
Risk Factors
/
Arteriovenous Fistula
/
Renal Dialysis
/
Ocimum basilicum
/
Renal Insufficiency, Chronic
Type of study:
Etiology study
/
Incidence study
/
Prevalence study
/
Prognostic study
/
Risk factors
Limits:
Humans
Language:
English
Journal:
Kidney Research and Clinical Practice
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS